These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25526438)

  • 21. Efficacy and safety of sofosbuvir plus ribavirin for treatment of cirrhotic patients with genotype 4 hepatitis C virus in real-life clinical practice.
    Abd-Elsalam S; Sharaf-Eldin M; Soliman S; Elfert A; Badawi R; Ahmad YK
    Arch Virol; 2018 Jan; 163(1):51-56. PubMed ID: 28983675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determinants of Infection Outcome in HCV-Genotype 4.
    Zayed RA; Omran D; Zayed AA; Elmessery LO
    Viral Immunol; 2017 Oct; 30(8):560-567. PubMed ID: 28731371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiviral regimen complexity index as an independent predictor of sustained virologic response in patients with chronic hepatitis C.
    Galán RJ; Cidoncha EC; Martin MF; Rodriguez CC; Almeida CV; Verdugo RM
    J Manag Care Pharm; 2013; 19(6):448-53. PubMed ID: 23806058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of occult hepatitis C virus infection in patients who achieved sustained virologic response to direct-acting antiviral agents.
    Yousif MM; Elsadek Fakhr A; Morad EA; Kelani H; Hamed EF; Elsadek HM; Zahran MH; Fahmy Afify A; Ismail WA; Elagrody AI; Ibrahim NF; Amer FA; Zaki AM; Sadek AMEM; Shendi AM; Emad G; Farrag HA
    Infez Med; 2018 Sep; 26(3):237-243. PubMed ID: 30246766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of chronic hepatitis C virus genotypes among patients between 21 to 65 years old in Puerto Rico.
    Rodríguez-Pérez F; Suárez-Pérez E; Alvarez-Rohena M; Toro DH
    P R Health Sci J; 2004 Jun; 23(2 Suppl):49-56. PubMed ID: 16929587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of human cytomegalovirus co-infection in Egyptian chronic HCV patients.
    Tabll A; Shoman S; Ghanem H; Nabil M; El Din NG; El Awady MK
    Virol J; 2011 Jul; 8():343. PubMed ID: 21740595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for hepatitis C virus infection among Egyptian healthcare workers in a national liver diseases referral centre.
    Abdelwahab S; Rewisha E; Hashem M; Sobhy M; Galal I; Allam WR; Mikhail N; Galal G; El-Tabbakh M; El-Kamary SS; Waked I; Strickland GT
    Trans R Soc Trop Med Hyg; 2012 Feb; 106(2):98-103. PubMed ID: 22197011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Younger trend of cirrhosis incidence in genotype 3 HCV infected patients in Eastern China.
    Lu J; Xiang X; Cao Z; Wang W; Zhao G; Tang W; Chen L; Guo S; Zhuang Y; Shi D; Chen L; Bao S; Cai W; Wang H; Zhou H; Xie Q
    J Med Virol; 2017 Nov; 89(11):1973-1980. PubMed ID: 28671305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C viral load and genotypes among Nigerian subjects with chronic infection and implication for patient management: a retrospective review of data.
    Audu RA; Okwuraiwe AP; Ige FA; Adeleye OO; Onyekwere CA; Lesi OA
    Pan Afr Med J; 2020; 37():335. PubMed ID: 33738023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of hepatic fibrosis by fibroscan in egyptian chronic hemodialysis patients with chronic Hepatitis C (genotype 4): A single-center study.
    Zayed BEM; Elsharkawy A; Abdou M; Abd Al Fatah DS; El-Shabony TH
    Saudi J Kidney Dis Transpl; 2017; 28(4):764-773. PubMed ID: 28748878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic hepatitis c genotype-4 infection: role of insulin resistance in hepatocellular carcinoma.
    Mohamed AA; Loutfy SA; Craik JD; Hashem AG; Siam I
    Virol J; 2011 Nov; 8():496. PubMed ID: 22044490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-invasive prediction of liver-related events in patients with HCV-associated compensated advanced chronic liver disease after oral antivirals.
    Pons M; Rodríguez-Tajes S; Esteban JI; Mariño Z; Vargas V; Lens S; Buti M; Augustin S; Forns X; Mínguez B; Genescà J
    J Hepatol; 2020 Mar; 72(3):472-480. PubMed ID: 31629779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Profiles and clinical management of hepatitis C patients in Spain: disHCovery study.
    Buti M; Franco A; Carmona I; Sánchez-Ruano JJ; Sansó A; Berenguer M; García-Buey L; Hernández-Guerra M; Morillas RM; Ledesma F; Esteban R;
    Rev Esp Quimioter; 2015 Jun; 28(3):145-53. PubMed ID: 26032999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic distance and heterogenecity between quasispecies is a critical predictor to IFN response in Egyptian patients with HCV genotype-4.
    Zekri AR; El-Din HM; Bahnassy AA; Khaled MM; Omar A; Fouad I; El-Hefnewi M; Thakeb F; El-Awady M
    Virol J; 2007 Feb; 4():16. PubMed ID: 17300723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ombitasvir, paritaprevir, and ritonavir plus ribavirin in adults with hepatitis C virus genotype 4 infection and cirrhosis (AGATE-I): a multicentre, phase 3, randomised open-label trial.
    Asselah T; Hézode C; Qaqish RB; ElKhashab M; Hassanein T; Papatheodoridis G; Feld JJ; Moreno C; Zeuzem S; Ferenci P; Yu Y; Redman R; Pilot-Matias T; Mobashery N
    Lancet Gastroenterol Hepatol; 2016 Sep; 1(1):25-35. PubMed ID: 28404108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The assessment of data mining for the prediction of therapeutic outcome in 3719 Egyptian patients with chronic hepatitis C.
    Zayed N; Awad AB; El-Akel W; Doss W; Awad T; Radwan A; Mabrouk M
    Clin Res Hepatol Gastroenterol; 2013 Jun; 37(3):254-61. PubMed ID: 23141214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Investigation of hepatitis C virus genotype distribution in patients with chronic hepatitis C infections in Antalya Training and Research Hospital, Turkey].
    Çekın Y; Gür N; Çekın AH; Altuğlu İ; Yazan Sertöz R
    Mikrobiyol Bul; 2014 Jul; 48(3):484-90. PubMed ID: 25052115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of hepatitis B and C in children.
    El-Shabrawi M; Hassanin F
    Minerva Pediatr; 2014 Oct; 66(5):473-89. PubMed ID: 25253190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seroprevalence and mother-to-infant transmission of hepatitis C in asymptomatic Egyptian women.
    Kumar RM; Frossad PM; Hughes PF
    Eur J Obstet Gynecol Reprod Biol; 1997 Dec; 75(2):177-82. PubMed ID: 9447371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.